IQVIA HOLDINGS INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
IQVIA HOLDINGS INC. (IQV) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 4.37% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2026-02-17
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2017-09-30 was 2.15%, a 58.09% increase year-over-year.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2017-06-30 was 2.13%, a 73.17% increase year-over-year.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2017-03-31 was 2.21%, a 40.76% increase year-over-year.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2016-09-30 was 1.36%, a 25.68% decline year-over-year.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2025 was 4.37%, a 4.17% decline from fiscal 2024.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2024 was 4.56%, a 4.00% decline from fiscal 2023.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2023 was 4.75%, a 12.56% increase from fiscal 2022.
- IQVIA HOLDINGS INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2022 was 4.22%, a 201.43% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|---|---|---|
| 2025-12-31 | 4.37% 10-K · filed 2026-02-17 | |||
| 2024-12-31 | 4.56% 10-K · filed 2026-02-17 | |||
| 2023-12-31 | 4.75% 10-K · filed 2026-02-17 | |||
| 2022-12-31 | 4.22% 10-K · filed 2025-02-13 | |||
| 2021-12-31 | 1.40% 10-K · filed 2024-02-15 | |||
| 2020-12-31 | 1.41% 10-K · filed 2023-02-15 | |||
| 2019-12-31 | 2.56% 10-K · filed 2022-02-16 | |||
| 2018-12-31 | 3.00% 10-K · filed 2021-02-12 | |||
| 2017-12-31 | 2.32% 10-K · filed 2020-02-18 | |||
| 2017-09-30 | 2.15% 10-Q · filed 2017-10-27 | 2.21% 10-Q · filed 2017-10-27 | ||
| 2017-06-30 | 2.13% 10-Q · filed 2017-08-04 | 2.21% 10-Q · filed 2017-08-04 | ||
| 2017-03-31 | 2.21% 10-Q · filed 2017-05-08 | |||
| 2016-12-31 | 2.19% 10-K · filed 2019-02-19 | |||
| 2016-09-30 | 1.36% 10-Q · filed 2017-10-27 | 1.57% 10-Q · filed 2017-10-27 | ||
| 2016-06-30 | 1.23% 10-Q · filed 2017-08-04 | 1.57% 10-Q · filed 2017-08-04 | ||
| 2016-03-31 | 1.57% 10-Q · filed 2017-05-08 | |||
| 2015-12-31 | 2.04% 10-K · filed 2018-02-16 | |||
| 2015-09-30 | 1.83% 10-Q · filed 2016-11-03 | 2.00% 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | 2.00% 10-Q · filed 2016-07-27 | 2.00% 10-Q · filed 2016-07-27 | ||
| 2015-03-31 | 1.88% 10-Q · filed 2016-05-03 | |||
| 2014-12-31 | 2.21% 10-K · filed 2017-02-16 | |||
| 2014-09-30 | 2.21% 10-Q · filed 2015-10-28 | |||
| 2014-06-30 | 2.13% 10-Q · filed 2015-07-29 | 2.21% 10-Q · filed 2015-07-29 | ||
| 2014-03-31 | 2.21% 10-Q · filed 2015-04-29 | |||
| 2013-12-31 | 2.24% 10-K · filed 2016-02-11 | |||
| 2013-09-30 | 2.08% 10-Q · filed 2014-10-30 | 2.08% 10-Q · filed 2014-10-30 | ||
| 2013-06-30 | 1.80% 10-Q · filed 2014-07-31 | 1.80% 10-Q · filed 2014-07-31 | ||
| 2013-03-31 | 1.19% 10-Q · filed 2014-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |